UBC investigators report the success of triple drug therapy at the Vancouver International AIDS Conference. New standard of care incorporating viral load monitoring and trip therapy is unveiled at this conference.
B.C. becomes the first Canadian province to adopt triple drug therapy and viral load testing for all eligible patients in a publicly funded plan and immediately sees dramatically reduced HIV/AIDS related morbidity and mortality.
BC-CfE research findings revealed an explosive outbreak of HIV and hepatitis C in injection drug users in Vancouver’s Downtown Eastside.
